Abstract: Novel meta substituted arylakylamine compounds are disclosed. These compounds can be administered as small molecule drugs to treat diseases or conditions associated with insufficient serotonin mediated nerve transmission (e.g. depression and obesity).

Abstract: A process for the continuous disposal of radioactive waste is disclosed. The process involves (a) separating materials contaminated with radionuclides into categories containing radionuclides with similar half-lives; (b) accumulating radioactive materials for each category in containers over a predetermined time interval; (c) sealing the containers and storing them until the radioactivity is reduced to safe levels; (d) disposing of the material as conventional waste; and (e) repeating steps (a) through (d) with a new batch of material. The method can be practically used to process radioactive wastes having half-lives of up to 50 years.